These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17366659)

  • 61. Effect of sepsis therapies on health-related quality of life.
    Erickson SE; Martin GS
    Crit Care; 2008; 12(1):109. PubMed ID: 18254930
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Clinical approach to the identification of patients suffering from severe sepsis with several organ failures for the administration of drotrecogin alfa (activated): from the PROWESS study to clinical practice].
    Dhainaut JF; Payen DM; Bernardin G; Gérard JL; Martin C; Perrotin D; Regnier B
    Ann Fr Anesth Reanim; 2003 Dec; 22 Spec No 1():53-64. PubMed ID: 15359946
    [No Abstract]   [Full Text] [Related]  

  • 63. Statistical analysis plan of PROWESS SHOCK study.
    ; Thompson BT; Ranieri VM; Finfer S; Barie PS; Dhainaut JF; Douglas IS; Gårdlund B; Marshall JC; Rhodes A
    Intensive Care Med; 2010 Nov; 36(11):1972-3. PubMed ID: 20689934
    [No Abstract]   [Full Text] [Related]  

  • 64. Brief report: tuberculosis sepsis and activated protein C.
    Rubin ZA; Leonard MK; Martin GS
    Am J Med Sci; 2006 Jul; 332(1):48-50. PubMed ID: 16845244
    [No Abstract]   [Full Text] [Related]  

  • 65. Adventure of recombinant human activated protein C in sepsis and new treatment hopes on the horizon.
    Kaya S
    Recent Pat Inflamm Allergy Drug Discov; 2012 May; 6(2):159-64. PubMed ID: 22292553
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immunomodulation in sepsis: state of the art and future perspective.
    Antonopoulou A; Giamarellos-Bourboulis EJ
    Immunotherapy; 2011 Jan; 3(1):117-28. PubMed ID: 21174562
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Activated protein C in severe Plasmodium falciparum malaria].
    Soto-Blanco JM; Yuste-Osorio E; Olivencia-Peña L; Matarán-Robles E
    Med Clin (Barc); 2011 May; 136(14):648-9. PubMed ID: 21051059
    [No Abstract]   [Full Text] [Related]  

  • 68. [Is there a place for activated protein C (Xigris) in the treatment of severe imported malaria in the adult?].
    Nau A; Peytel E; Petrognani R
    Ann Fr Anesth Reanim; 2006 Oct; 25(10):1085-6. PubMed ID: 17005364
    [No Abstract]   [Full Text] [Related]  

  • 69. Septic shock--evaluating another failed treatment.
    Wenzel RP; Edmond MB
    N Engl J Med; 2012 May; 366(22):2122-4. PubMed ID: 22616829
    [No Abstract]   [Full Text] [Related]  

  • 70. The Surviving Sepsis Campaign guidelines: should we follow?
    Singer P; Cohen JD
    Isr Med Assoc J; 2011 Nov; 13(11):692-3. PubMed ID: 22279705
    [No Abstract]   [Full Text] [Related]  

  • 71. Advances in the management of sepsis and the understanding of key immunologic defects.
    Skrupky LP; Kerby PW; Hotchkiss RS
    Anesthesiology; 2011 Dec; 115(6):1349-62. PubMed ID: 21952252
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Innovation in sepsis management. Introduction.
    Rihn TL
    Am J Health Syst Pharm; 2002 Feb; 59 Suppl 1():S2-3. PubMed ID: 11885410
    [No Abstract]   [Full Text] [Related]  

  • 73. Anaesthetic management of patients with severe sepsis.
    Gibson B; Terblanche C
    Br J Anaesth; 2011 Mar; 106(3):416-7; author reply 417. PubMed ID: 21317227
    [No Abstract]   [Full Text] [Related]  

  • 74. The authors reply.
    Rimmer E; Kumar A; Zarychanski R
    Crit Care Med; 2013 Jul; 41(7):e139-40. PubMed ID: 23774364
    [No Abstract]   [Full Text] [Related]  

  • 75. Sepsis: taking a deeper look.
    Cheek DJ; McGehee-Smith H; Cunneen J; Cartwright M
    Nursing; 2005 Jan; 35(1):38-42; quiz 42-3. PubMed ID: 15622203
    [No Abstract]   [Full Text] [Related]  

  • 76. Factors influencing clinician's coherence with local antimicrobial guidelines in the management of sepsis.
    McNulty P; Szakmany T;
    Anaesthesiol Intensive Ther; 2018; 50(1):82-84. PubMed ID: 29637992
    [No Abstract]   [Full Text] [Related]  

  • 77. Interleukin-6.
    Song M; Kellum JA
    Crit Care Med; 2005 Dec; 33(12 Suppl):S463-5. PubMed ID: 16340422
    [No Abstract]   [Full Text] [Related]  

  • 78. Call for a greater focus on sepsis.
    Calkin S
    Nurs Times; 2014 Sep 10-16; 110(37):2-3. PubMed ID: 25318139
    [No Abstract]   [Full Text] [Related]  

  • 79. Management of sepsis.
    Khurana A; Vinayek N
    N Engl J Med; 2007 Mar; 356(11):1178-9; author reply 1181-2. PubMed ID: 17366659
    [No Abstract]   [Full Text] [Related]  

  • 80. Treatment of severe sepsis and septic shock in critically ill patients.
    Namendys-Silva SA; Hernández-Garay M
    Heart Lung; 2012; 41(4):408-9. PubMed ID: 22534210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.